Department of Endocrinology, Gateshead Health NHS Foundation Trust, Gateshead, UK.
Hadrian Primary Care Alliance, West Northumberland, UK.
Clin Endocrinol (Oxf). 2017 Dec;87(6):860-864. doi: 10.1111/cen.13440. Epub 2017 Aug 29.
Hypothyroidism is more frequently diagnosed in women and older individuals. It has been suggested that the prevalence of hypothyroidism and the number of prescriptions for thyroid hormones are increasing. However, despite hypothyroidism being a common medical condition, contemporary data on prevalence, particularly across the various age groups, is limited.
Information regarding number of individuals diagnosed with treated hypothyroidism (defined as patients prescribed levothyroxine) across ten General Practices (total population of 66 843) in the North-East of England in 2016 was obtained in an anonymized manner. Total as well as age group-specific point prevalence rates were calculated. In addition, corresponding population data for the United Kingdom were acquired, and national total and age-specific hypothyroidism prevalence rates were estimated.
The overall prevalence of hypothyroidism in this community sample was 4.5% (n = 3004). Prevalence increased across the age groups from 0.1% in children aged 0-10 years to 15.1% in those aged more than 90 years. After adjusting for demographic differences between the North-East England and UK populations, it is estimated that the total UK-wide prevalence of hypothyroidism in 2016 is 3.6%; affecting more than 2.3 million individuals including nearly 800 000 individuals aged >70 years.
Hypothyroidism affects millions of individuals in the UK and is currently a prevalent diagnosis in more than 1 in 10 individuals aged above 70 years. As the population ages this number is likely to increase. The clinical and economic effects of current management strategies for hypothyroidism, particularly in the older population, need to be evaluated.
甲状腺功能减退症在女性和老年人中更为常见。有人认为,甲状腺功能减退症的患病率和甲状腺激素的处方数量正在增加。然而,尽管甲状腺功能减退症是一种常见的疾病,但关于患病率的当代数据,特别是在各个年龄段,是有限的。
以匿名方式获取了 2016 年英格兰东北部的 10 家全科医生(总人群为 66843 人)中诊断为治疗性甲状腺功能减退症(定义为开具左甲状腺素的患者)的人数信息。计算了总患病率和年龄组特异性点患病率。此外,还获取了英国相应的人口数据,并估计了全国总患病率和年龄特异性甲状腺功能减退症患病率。
该社区样本中甲状腺功能减退症的总体患病率为 4.5%(n=3004)。患病率随着年龄组的增加而增加,从 0-10 岁儿童的 0.1%增加到 90 岁以上的 15.1%。在调整了英格兰东北部和英国人口之间的人口统计学差异后,估计 2016 年英国全国范围内甲状腺功能减退症的总患病率为 3.6%;影响超过 230 万人,其中包括近 800 000 名年龄>70 岁的人。
甲状腺功能减退症影响英国数百万人,目前在超过 1/10 的年龄在 70 岁以上的人中被诊断为常见疾病。随着人口老龄化,这个数字可能会增加。当前甲状腺功能减退症管理策略的临床和经济影响,特别是在老年人群中,需要进行评估。